Genmab A/S (GMAB) Stock Chart & Stock Price History $22.67 +0.80 (+3.66%) Closing price 08/13/2025 04:00 PM EasternExtended Trading$22.80 +0.13 (+0.60%) As of 08:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Genmab A/S Stock Price Performance The Genmab A/S (GMAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 15.41%, with a year-to-date return of 8.62%. In the past month, the stock has increased 5.64%, reflecting recent market activity. As of the latest close, Genmab A/S traded at $22.67 with a market cap of $14.54 billion and volume of 827,040 shares. Five years ago, the stock traded at $36.92, representing a 38.60% decrease over that period. At the time, it had a market cap of $23.30 billion and a volume of 706,570 shares. Receive GMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.79%1 Month Performance+5.64%3 Month Performance+18.82%Year-To-Date Performance+8.62%1 Year Performance-15.41%5 Year Performance-38.60% GMAB Stock Chart for Thursday, August, 14, 2025 GMAB Chart by TradingView Genmab A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/13/2025$21.87$22.67+3.66%$22.69$22.18827,040 shs$14.54 billion08/12/2025$21.08$21.87+3.75%$21.88$21.171.16 million shs$14.03 billion08/11/2025$21.43$21.08-1.63%$21.28$21.00982,925 shs$13.52 billion08/08/2025$22.69$21.43-5.55%$21.66$21.271.75 million shs$13.75 billion08/07/2025$21.51$22.69+5.49%$22.90$21.863.06 million shs$14.56 billion08/06/2025$22.10$21.51-2.67%$21.72$21.381.51 million shs$13.80 billion08/05/2025$21.98$22.10+0.55%$22.27$21.97776,368 shs$14.18 billion08/04/2025$21.78$21.98+0.92%$22.06$21.69967,090 shs$14.10 billion08/01/2025$21.67$21.78+0.51%$21.79$21.261.20 million shs$13.97 billion07/31/2025$22.27$21.67-2.69%$22.09$21.64783,779 shs$13.90 billion Get the Latest News and Ratings for GMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 07/30/2025$22.60$22.27-1.46%$22.56$22.18709,406 shs$14.29 billion07/29/2025$23.09$22.60-2.12%$22.81$22.57826,764 shs$14.50 billion07/28/2025$23.40$23.09-1.32%$23.40$23.08652,045 shs$14.81 billion07/25/2025$23.63$23.40-0.97%$23.44$23.19713,820 shs$15.01 billion07/24/2025$22.87$23.63+3.32%$23.87$23.461.54 million shs$15.16 billion07/23/2025$21.80$22.87+4.91%$22.92$22.511.80 million shs$14.67 billion07/22/2025$21.69$21.80+0.51%$21.86$21.59834,789 shs$13.99 billion07/21/2025$21.88$21.69-0.87%$21.83$21.61635,193 shs$13.92 billion07/18/2025$22.01$21.88-0.59%$22.30$21.82837,917 shs$14.04 billion07/17/2025$21.87$22.01+0.64%$22.17$21.82915,174 shs$14.12 billion07/16/2025$21.15$21.87+3.40%$21.89$21.411.05 million shs$14.03 billion07/15/2025$21.46$21.15-1.44%$21.59$21.101.04 million shs$13.57 billion07/14/2025$21.40$21.46+0.28%$21.48$21.26598,453 shs$13.77 billion Related Companies Takeda Pharmaceutical Stock Chart argenex Stock Chart BeOne Medicines Stock Chart BioNTech Stock Chart Insmed Stock Chart Summit Therapeutics Stock Chart Teva Pharmaceutical Industries Stock Chart Ascendis Pharma A/S Stock Chart Viatris Stock Chart Dr. Reddy's Laboratories Stock Chart Receive GMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMAB) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access